Michael Kishbauch

2012

In 2012, Michael Kishbauch earned a total compensation of $3M as Director, Former President and Chief Executive Officer Retired at Achillion Pharmaceuticals, a 111% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$292,338
Option Awards$2,225,721
Salary$470,300
Other$7,833
Total$2,996,192

Kishbauch received $2.2M in option awards, accounting for 74% of the total pay in 2012.

Kishbauch also received $292.3K in non-equity incentive plan, $470.3K in salary and $7.8K in other compensation.

Rankings

In 2012, Michael Kishbauch's compensation ranked 2,336th out of 11,487 executives tracked by ExecPay. In other words, Kishbauch earned more than 79.7% of executives.

ClassificationRankingPercentile
All
2,336
out of 11,487
80th
Division
Manufacturing
810
out of 4,253
81st
Major group
Chemicals And Allied Products
181
out of 1,198
85th
Industry group
Drugs
105
out of 920
89th
Industry
Pharmaceutical Preparations
85
out of 700
88th
Source: SEC filing on April 18, 2014.

Kishbauch's colleagues

We found four more compensation records of executives who worked with Michael Kishbauch at Achillion Pharmaceuticals in 2012.

2012

Gautam Shah

Achillion Pharmaceuticals

Former Executive Vice President and Chief Compliance Officer

2012

Milind Deshpande

Achillion Pharmaceuticals

Chief Executive Officer

2012

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

2012

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

In-depth

You may also like